Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
NumeralJSE:XII 18 Pretax Margin % is 12.42% as of May. 2026, which is 42% below its 10-year median of 21.46. GuruFocus rates JSE:XII with a GF Score™ of 18/100. The stock has 5 warning signs investors should review. Among 957 Drug Manufacturers companies, Numeral ranks better than 57.58% on this metric.
Pre-Tax margin is calculated as Pre-Tax Income divided by its Revenue. Numeral's Pre-Tax Income for the
three
months ended in May. 2026 was R0.96 Mil. Numeral's Revenue for the
three
months ended in May. 2026 was R7.70 Mil. Therefore, Numeral's pretax margin for the quarter that ended in May. 2026 was 12.42%.
The historical rank and industry rank for Numeral's Pretax Margin % or its related term are showing as below:
JSE:XII'
s Pretax Margin % Range Over the Past 10 Years
Min: 8.18 Med: 21.46 Max: 37.44
Current: 9.93
JSE:XII's Pretax Margin % is ranked better than 57.58% of 957
companies
in the Drug Manufacturers industry
Industry Median: 7.62
vs JSE:XII: 9.93
The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.
The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.
It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.
The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.
Numeral Pretax Margin % Related Terms
Numeral Pretax Margin % Historical Data
* Premium members only.
The historical data trend for Numeral's Pretax Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
JSE:XII vs ZTS, UTHR, VTRS: Pretax Margin % Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Numeral's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Numeral Pretax Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Numeral's Pretax Margin % distribution charts can be found below:
* The bar in red indicates where Numeral's Pretax Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Numeral (JSE:XII) has a Pretax Margin % of 12.42% as of May. 2026. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Numeral and its competitors. This is 42% below median its historical median of 21.46. Over the past decade, Numeral's Pretax Margin % has ranged from 8.18 to 37.44. According to the industry distribution chart, Numeral ranks #406 out of 957 companies in the Drug Manufacturers industry, placing it in the top 42.4%.
Is Numeral's Pretax Margin % too high?
Numeral's current Pretax Margin % of 12.42% is 42% below median its 10-year median of 21.46. Over the past 10 years, this metric has ranged from a low of 8.18 to a high of 37.44. The Drug Manufacturers industry median Pretax Margin % is 7.62. Numeral's value of 12.42% is 63% above this industry median. Based on the distribution chart, Numeral ranks #406 out of 957 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Numeral has a GF Score™ of 18/100, reflecting its overall financial health beyond just this single metric.
How does Numeral's Pretax Margin % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Numeral ranks #406 out of 957 companies for Pretax Margin %. This puts Numeral in the upper half of its industry. The industry median Pretax Margin % is 7.62. Numeral's value of 12.42% is 63% above this benchmark. Historically, Numeral's own Pretax Margin % has ranged from 8.18 to 37.44 over the past decade. While the company's 10-year median is 21.46 vs. the industry median of 7.62, Numeral has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Pretax Margin % for a Drug Manufacturers company?
The median Pretax Margin % among Drug Manufacturers companies is 7.62, based on 957 companies in the industry. Companies in the top quartile (top 25%) have a Pretax Margin % significantly above this median, while those in the bottom quartile fall well below. However, Pretax Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Numeral's current Pretax Margin % of 12.42% is 63% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Pretax Margin % mean?
A high Pretax Margin % can signal that a stock is expensive relative to its fundamentals. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Numeral and its competitors. For the Drug Manufacturers industry, the median Pretax Margin % is 7.62 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Numeral's current Pretax Margin % is 12.42%, which is 42% below median its own 10-year median of 21.46. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Numeral stock overvalued right now?
Numeral (JSE:XII) has a current Pretax Margin % of 12.42%. The current Pretax Margin % is 12.42%, which is 42% below median its 10-year median of 21.46 and 63% above the Drug Manufacturers industry median of 7.62. Numeral's overall GF Score™ is 18/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Pretax Margin % calculated?
Pretax Margin % is calculated from a company's financial statements. For Numeral (JSE:XII), the current Pretax Margin % is 12.42% as of May. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Numeral Ltd is an investment holding company based in Mauritius with a focus on fintech, biotechnology, and asset management. Geographically it has a presence in countries across Africa, Europe and Asia. The majority of its revenue is generated in the form of Trading income.
18GF Score
Get the complete analysis for JSE:XII
Pretax Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
JSE:XII has been successfully added to your 
